Sixten Harborg, MD
sixtenharborg.bsky.social
Sixten Harborg, MD
@sixtenharborg.bsky.social
Currently📍Visiting Research Scholar in the Eliassen lab @harvardHSPH @harvardHMS @MGB 🇺🇸 | PhD fellow in clinical oncology @oncaarhus @AUHdk @AarhusUni | Researches breast cancer | 🇸🇪 lost in 🇩🇰

Previously •Breast Cancer Research Updates• @X
Based on our findings and others, we propose that research is warranted into whether BC survivors might benefit from metabolic screening during their treatment course to improve their chances of avoiding a recurrence or death from their malignancy 🔬🧪🧑‍🔬
January 8, 2025 at 2:32 PM
More research is needed ❗️
January 8, 2025 at 2:32 PM
The molecular changes affecting breast cancer progression in women with metabolic syndrome are complex
January 8, 2025 at 2:32 PM
Recurrence and BC mortality 📈

Our analyses show that the presence of metabolic syndrome among BC survivors is equally harmful in people living in Europe, Asia or North America 🌍
January 8, 2025 at 2:32 PM
December 12, 2024 at 6:32 PM
The discussion turns towards a wish of longitudinal weight measures during follow-up 📊
December 12, 2024 at 6:32 PM
December 12, 2024 at 4:43 PM
Thank you so much! It was great chatting with you too and thank you for sharing your insights.
December 12, 2024 at 4:41 PM
Lifestyle interventions will need to be a vital parameter of future studies assessing GLP1ra’s role in adjuvant BC care❗️
December 12, 2024 at 4:18 PM
and future studies should carefully consider the ethics of inducing a weight loss with anti obesity medication in BC pts…if the drug is not efficacious it might leave pts with increased fat mass deposits when discontinuing the AOM.
December 12, 2024 at 4:18 PM
Still many questions to answer with regards to weight loss medications application in BC care❓

Prospective studies are needed❗️
December 12, 2024 at 4:18 PM